Simard John's Form 4 filing
XBiotech Inc. (XBIT) · filed Oct 15, 2021
- Accession no.
- 0001209191-21-060523
- Filed
- Oct 15, 2021
- Trade date
- Oct 7-14, 2021
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.13M. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simard JohnCIK 0001639078 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2021 | Common Stock | SSaleDisposed | −39,286 | $12.45 | −$489,110.7 | 3,923,166 | Direct | |
| Oct 12, 2021 | Common Stock | SSaleDisposed | −18,000 | $12.77 | −$229,860 | 3,973,166 | Direct | |
| Oct 13, 2021 | Common Stock | SSaleDisposed | −10,875 | $12.83 | −$139,526.25 | 3,962,452 | Direct | |
| Oct 14, 2021 | Common Stock | SSaleDisposed | −21,125 | $12.90 | −$272,512.5 | 3,873,166 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.